2021-01-07,ProQR Completes Enrollment of its Pivotal Trial of Sepofarsen for the Treatment of LCA10
2020-12-18,ProQR Announces Webcast of Presentation at Upcoming HC Wainwright BIOCONNECT Conference
2020-11-30,Hedge Funds Are Selling ProQR Therapeutics NV (PRQR)
2020-11-18,ProQR to Present at 3rd Annual Evercore ISI Virtual HealthCONx Conference
2020-11-17,How Is ProQR Therapeutics' (NASDAQ:PRQR) CEO Paid Relative To Peers?
2020-11-16,"ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates"
2020-11-16,ProQR Announces Third Quarter 2020 Operating and Financial Results
2020-11-02,ProQR Announces Virtual Presentations at American Academy of Ophthalmology (AAO)
2020-10-05,"ProQR Appoints Naveed Shams, MD, PhD as Chief Scientific Officer"
2020-09-24,ProQR Announces Virtual Presentations at Scientific Conferences
2020-09-21,Reflecting on ProQR Therapeutics' (NASDAQ:PRQR) Share Price Returns Over The Last Five Years
2020-09-03,ProQR to Participate in Upcoming Investor Conferences
2020-08-06,ProQR Announces Second Quarter 2020 Operating and Financial Results
2020-07-23,Analysts Are Betting On ProQR Therapeutics N.V. (NASDAQ:PRQR) With A Big Upgrade This Week
2020-07-21,ProQR Strengthens Scientific Advisory Board with Leaders in Inherited Retinal Disease and RNA Therapy
2020-07-14,ProQR Announces $30 Million Strategic Convertible Debt Financing Agreement with Pontifax Ventures
2020-07-13,ProQR Announces Expert Perspectives Call on LCA10 and Sepofarsen
2020-06-29,News Flash: Analysts Just Made A Stunning Upgrade To Their ProQR Therapeutics N.V. (NASDAQ:PRQR) Forecasts
2020-06-23,"The Zacks Analyst Blog Highlights: Smith & Wesson, Zscaler, Sportsman's Warehouse, ProQR and Ooma"
2020-06-22,Hedge Funds Souring On ProQR Therapeutics NV (PRQR)
2020-06-22,5 Must-Buy Low-Beta Stocks Flying High in a Volatile Market
2020-06-15,"Zacks.com featured highlights include: Frontline, iClick Interactive Asia, Avenue Therapeutics, ProQR Therapeutics and BJ???s Wholesale Club"
2020-06-12,ProQR Announces Expert Perspectives Conference Call Series
2020-06-08,ProQR Announces Virtual Presentation of Phase 1/2 Sepofarsen Data Through the Association for Research in Vision and Ophthalmology (ARVO)
2020-05-29,How ProQR (PRQR) Stock Stands Out in a Strong Industry
2020-05-25,ProQR Announces Annual Meeting of Shareholders
2020-05-07,"ProQR (PRQR) Reports Q1 Loss, Lags Revenue Estimates"
2020-05-07,ProQR Announces First Quarter 2020 Operating and Financial Results
2020-04-28,Does ProQR Therapeutics (NASDAQ:PRQR) Have A Healthy Balance Sheet?
2020-03-31,ProQR Announces Positive Findings From an Interim Analysis in the Phase 1/2 trial of QR-421a for Usher Syndrome and Provides Business Update
2020-03-25,ProQR to Present Findings from Phase 1/2 Interim Analysis of QR-421a for Usher Syndrome
2020-03-05,"Editas, Allergan Start Dosing in Early-Stage Eye Disease Study"
2020-02-28,How Much Did ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO Pocket Last Year?
2020-02-26,ProQR Announces Fourth Quarter and Full Year 2019 Results and Provides Business Update
2020-02-24,ProQR to Present at Cowen and Company 40th Annual Health Care Conference
2020-02-06,ProQR Therapeutics Teams Up with the Foundation Fighting Blindness and Blueprint Genetics to Support the My Retina TrackerÂ® Program for People Living with Inherited Retinal Diseases
2020-01-30,ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a
2020-01-21,3 Healthcare Stocks That Can Double in the Next Year
2020-01-06,Editas (EDIT) Focuses on Developing Eye Candidate EDIT-101
2019-12-23,Did Business Growth Power ProQR Therapeutics's (NASDAQ:PRQR) Share Price Gain of 119%?
2019-12-17,Did Hedge Funds Drop The Ball On ProQR Therapeutics NV (PRQR) ?
2019-12-12,ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study
2019-12-11,Vertex's Kalydeco Gets EU Approval to Treat CF in Infants
2019-12-11,ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa
2019-11-21,ProQR shares rises on FDA orphan drug designation
2019-11-21,ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa
2019-11-18,ProQR to Present at Upcoming Scientific Conferences
2019-11-13,ProQR to Present at Upcoming Investor Conferences
2019-11-06,Were Hedge Funds Right About Dumping ProQR Therapeutics NV (PRQR)?
2019-11-06,Blueprint Medicines (BPMC) Q3 Earnings &amp; Sales Top Estimates
2019-11-06,"ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates"
2019-11-06,ProQR Announces Recent Progress and Financial Results for the Third Quarter of 2019
2019-11-05,Acorda (ACOR) Q3 Earnings and Revenues Surpass Estimates
2019-10-24,BioMarin's (BMRN) Earnings &amp; Revenues Beat Estimates in Q3
2019-10-23,Will ProQR Therapeutics Continue to Surge Higher?
2019-10-18,ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters Option to Purchase Additional Shares
2019-10-16,"The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch"
2019-10-15,ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares
2019-10-15,ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
2019-10-15,ProQR Receives Rare Pediatric Disease Designation from FDA for Sepofarsen for the Treatment of LCA10
2019-10-10,"The Daily Biotech Pulse: UCB To Buy Ra Pharma, Reata Reacquires Rights To Nrf2 Activators From AbbVie, BioNTech IPO"
2019-10-10,ProQR Announces Positive Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients
2019-10-07,ProQR to Present Top-Line Results from the Phase 1/2 Study of Sepofarsen in LCA10 Patients ahead of AAO
2019-10-01,ProQR Therapeutics Enters Oversold Territory
2019-09-30,ProQR to Present at Two Investor Conferences in October
2019-09-24,Is ProQR Therapeutics (NASDAQ:PRQR) Using Too Much Debt?
2019-09-13,Vertex Gains Reimbursement for Orkambi &amp; Symkevi in Scotland
2019-09-09,ProQR Receives Fast Track Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa
2019-08-14,Vaccinex (VCNX) Attains Full Enrollment in Lung Cancer Study
2019-08-13,Mallinckrodt Enrolls First Patient in Liver Disease Study
2019-08-12,ProQR Announces Clearance of IND to Start Clinical Trial of QR-1123 in Patients with Autosomal Dominant Retinitis Pigmentosa (adRP)
2019-08-07,"ProQR (PRQR) Reports Q2 Loss, Misses Revenue Estimates"
2019-08-07,ProQR Announces Financial Results for the Second Quarter of 2019
2019-07-29,European Medicines Agency Grants PRIME Access to ProQRs Sepofarsen for Lebers Congenital Amaurosis 10
2019-07-26,What Did ProQR Therapeutics N.V.'s (NASDAQ:PRQR) CEO Take Home Last Year?
2019-07-02,ProQR Announces Presentation on QR-421a Program in Ophthalmology at Usher Syndrome Coalition Conference in July
2019-06-29,Heres What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
2019-06-03,ProQR to Present at the JMP Securities Life Sciences Conference
2019-05-27,Did Business Growth Power ProQR Therapeutics's (NASDAQ:PRQR) Share Price Gain of 153%?
2019-05-15,ProQR to Present at the RBC Capital Markets Healthcare Conference
2019-05-08,Here is What Hedge Funds Think About ProQR Therapeutics NV (PRQR)
2019-05-08,"ProQR (PRQR) Reports Q1 Loss, Misses Revenue Estimates"
2019-05-08,ProQR: 1Q Earnings Snapshot
2019-05-08,ProQR Announces Financial Results for the First Quarter of 2019
2019-04-22,ProQR to Present at Three Scientific Conferences in April
2019-04-18,"ProQR nominates Bart Filius, COO and CFO at Galapagos and Theresa Heggie, Head of CEMEA at Alnylam for its Supervisory Board"
2019-04-18,ProQR Announces Annual Meeting of Shareholders
2019-04-16,ProQR Initiates Dosing in Phase II/III Eye Disorder Study
2019-04-15,ProQR Doses First Patient in Phase 2/3 ILLUMINATE Trial of Sepofarsen for LCA10
2019-04-01,ProQR to Present at the H.C. Wainwright Global Life Sciences Conference
2019-03-26,ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics created by EB Research Partnership
2019-03-11,ProQR Doses First Patient in Phase 1/2 STELLAR Trial of QR-421a for Usher Syndrome Type 2
2019-03-05,ProQR to Present at Cowen Health Care Conference
2019-02-28,"Medicines Company (MDCO) Q4 Loss Widens, Inclisiran in Focus"
2019-02-27,ProQR Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
2019-02-21,Agios' Tibsovo Gets FDA Priority Review in First-Line Cancer
2019-01-29,Vertex's Kalydeco Wins Health Canada Nod to Treat CF in Kids
2019-01-29,ProQR Announces ProQR Vision 2023 Strategy at its Annual R&D Day
2019-01-22,Should You Worry About ProQR Therapeutics N.V.s (NASDAQ:PRQR) CEO Salary Level?
2019-01-07,ProQR Reaches Agreement with the FDA on Design of Phase 2/3 Pivotal Trial for Sepofarsen (QR-110) for Lebers Congenital Amaurosis 10
